ID

13000

Descripción

Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00041652

Link

https://clinicaltrials.gov/show/NCT00041652

Palabras clave

Versiones (1)
  1. 10/1/16 10/1/16 -
Subido en

10 de enero de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Colorectal Cancer NCT00041652

Inglés

Eligibility Colorectal Cancer NCT00041652

1 formularios  
Criteria
Descripción

Criteria

histologic or cytologic diagnosis or either, colonic, rectal, or breast carcinoma
Descripción

colonic, rectal or breast carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0699790
UMLS CUI [2]
C0007113
UMLS CUI [3]
C0678222
measurable lesion diagnosed by ct scan
Descripción

measurable disease

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0040405
UMLS CUI [1,2]
C1513041
recurrent/metastatic disease considered surgically unresectable.
Descripción

unresectable: relapse, metastasis

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0277556
UMLS CUI [1,2]
C1519810
UMLS CUI [2,1]
C0027627
UMLS CUI [2,2]
C1519810
prior/concurrent therapy:
Descripción

concurrent therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009429
chemotherapy: patients who either have failed at least one regimen of standard systemic therapy, or are clinically asymptomatic and are not presently being considered for chemotherapy (enrollment must occur at least 4 weeks beyond last treatment)
Descripción

chemotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0392920
other: prior treatment with investigational agents is excluded unless follow-up is completed and patient is off study
Descripción

study subject participation status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
performance status: patients with a karnofsky performance status > 70% (or equivalent, ecog 0-1) and expected survival of at least 3 months.
Descripción

karnofsky, ecog, life expectancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0206065
UMLS CUI [2]
C1520224
UMLS CUI [3]
C0023671
hematopoietic: wbc >/= 3000 mm3, neutrophils >/= 1500 mm3, platelets >/= 75,000, cea < 300 ng/ml
Descripción

wbc, neutrophils, platelets

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023508
UMLS CUI [2]
C0200633
UMLS CUI [3]
C0032181
hepatic: serum bilirubin </= 2.0 mg/dl, alt < 2.5 x iuln
Descripción

bilirubin

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1278039
cardiovascular: patients with lvef >/= 40% by required muga/2d-echo study.
Descripción

lvef

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0428772
pulmonary: patients with fev1 >/= 60% by required pulmonary function tests
Descripción

fev1

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0748133
other: patients agreeing to use a medically effective method of contraception during and for a period of 3 months after the treatment period. a pregnancy test will be preformed on each premenopausal female of childbearing potential immediately prior to entry into the study. patients able to understand and give written informed consent. patients with a significant concurrent medical condition that could affect the patient's ability to tolerate or complete the study.
Descripción

contraception, pregnancy test, informed consent, comorbidity

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0700589
UMLS CUI [2]
C0032976
UMLS CUI [3]
C0021430
UMLS CUI [4,1]
C1321605
UMLS CUI [4,2]
C0439801
UMLS CUI [4,3]
C0009488
Volver a la parte superior de la página

Similar models

Eligibility Colorectal Cancer NCT00041652

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
colonic, rectal or breast carcinoma
Item
histologic or cytologic diagnosis or either, colonic, rectal, or breast carcinoma
boolean
C0699790 (UMLS CUI [1])
C0007113 (UMLS CUI [2])
C0678222 (UMLS CUI [3])
measurable disease
Item
measurable lesion diagnosed by ct scan
boolean
C0040405 (UMLS CUI [1,1])
C1513041 (UMLS CUI [1,2])
unresectable: relapse, metastasis
Item
recurrent/metastatic disease considered surgically unresectable.
boolean
C0277556 (UMLS CUI [1,1])
C1519810 (UMLS CUI [1,2])
C0027627 (UMLS CUI [2,1])
C1519810 (UMLS CUI [2,2])
concurrent therapy
Item
prior/concurrent therapy:
boolean
C0009429 (UMLS CUI [1])
chemotherapy
Item
chemotherapy: patients who either have failed at least one regimen of standard systemic therapy, or are clinically asymptomatic and are not presently being considered for chemotherapy (enrollment must occur at least 4 weeks beyond last treatment)
boolean
C0392920 (UMLS CUI [1])
study subject participation status
Item
other: prior treatment with investigational agents is excluded unless follow-up is completed and patient is off study
boolean
C2348568 (UMLS CUI [1])
karnofsky, ecog, life expectancy
Item
performance status: patients with a karnofsky performance status > 70% (or equivalent, ecog 0-1) and expected survival of at least 3 months.
boolean
C0206065 (UMLS CUI [1])
C1520224 (UMLS CUI [2])
C0023671 (UMLS CUI [3])
wbc, neutrophils, platelets
Item
hematopoietic: wbc >/= 3000 mm3, neutrophils >/= 1500 mm3, platelets >/= 75,000, cea < 300 ng/ml
boolean
C0023508 (UMLS CUI [1])
C0200633 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
bilirubin
Item
hepatic: serum bilirubin </= 2.0 mg/dl, alt < 2.5 x iuln
boolean
C1278039 (UMLS CUI [1])
lvef
Item
cardiovascular: patients with lvef >/= 40% by required muga/2d-echo study.
boolean
C0428772 (UMLS CUI [1])
fev1
Item
pulmonary: patients with fev1 >/= 60% by required pulmonary function tests
boolean
C0748133 (UMLS CUI [1])
contraception, pregnancy test, informed consent, comorbidity
Item
other: patients agreeing to use a medically effective method of contraception during and for a period of 3 months after the treatment period. a pregnancy test will be preformed on each premenopausal female of childbearing potential immediately prior to entry into the study. patients able to understand and give written informed consent. patients with a significant concurrent medical condition that could affect the patient's ability to tolerate or complete the study.
boolean
C0700589 (UMLS CUI [1])
C0032976 (UMLS CUI [2])
C0021430 (UMLS CUI [3])
C1321605 (UMLS CUI [4,1])
C0439801 (UMLS CUI [4,2])
C0009488 (UMLS CUI [4,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial